BioPure
College Station, US · 1 known investors
Find your way into BioPure
Bondwell Technologies develops protein-based materials for bioprocessing and biomanufacturing applications. The company's technology, discovered by academic researchers, is being scaled for commercial use in pharmaceutical, medical device, and regenerative medicine sectors.
Founders & leadership
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $235.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2019 | $248.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does BioPure do?
- Bondwell Technologies develops protein-based materials for bioprocessing and biomanufacturing applications. The company's technology, discovered by academic researchers, is being scaled for commercial use in pharmaceutical, medical device, and regenerative medicine sectors.
- Who founded BioPure?
- BioPure was founded by Kristin A. Howell.
- Who are BioPure's investors?
- BioPure's investors include Aggie Angel Network.
- Where is BioPure headquartered?
- BioPure is headquartered in College Station, US.